Past, present, and future of antifungal drug development
PK Shukla, P Singh, RK Yadav, S Pandey… - … Diseases of the …, 2018 - Springer
Fungi are eukaryotic, single cell or multicellular organisms which cause a wide range of
human diseases ranging from superficial skin to invasive life-threatening infections. Over the …
human diseases ranging from superficial skin to invasive life-threatening infections. Over the …
[PDF][PDF] Antifungal agents: Polyene, azole, antimetabolite, other and future agents
Antifungals have always been considered as one of the astonishing discoveries of the 20th
century. This is correct, but the real marvel is the development of antifungal resistance in …
century. This is correct, but the real marvel is the development of antifungal resistance in …
Discovery and development of antifungal compounds
M Kidwai, R Venkataramanan… - … -Anti-Infective Agents, 2003 - ingentaconnect.com
Antifungal agents constitute a major part of antiinfective drugs and have been in practice
since 16th century. Antifungal agents generally belong to the class of polyenes, azoles …
since 16th century. Antifungal agents generally belong to the class of polyenes, azoles …
[HTML][HTML] Sources of antifungal drugs
G Vanreppelen, J Wuyts, P Van Dijck, P Vandecruys - Journal of Fungi, 2023 - mdpi.com
Due to their eukaryotic heritage, the differences between a fungal pathogen's molecular
makeup and its human host are small. Therefore, the discovery and subsequent …
makeup and its human host are small. Therefore, the discovery and subsequent …
Recent drug development and treatments for fungal infections
M Roy, S Karhana, M Shamsuzzaman… - Brazilian Journal of …, 2023 - Springer
Fungal infections are now becoming a hazard to individuals which has paved the way for
research to expand the therapeutic options available. Recent advances in drug design and …
research to expand the therapeutic options available. Recent advances in drug design and …
Antifungals: mechanism of action and resistance, established and novel drugs
NH Georgopapadakou - Current opinion in microbiology, 1998 - Elsevier
Serious fungal infections, caused mostly by opportunistic species, are increasingly common
in immunocompromised and other vulnerable patients. The use of antifungal drugs, primarily …
in immunocompromised and other vulnerable patients. The use of antifungal drugs, primarily …
Potential targets for the development of new antifungal drugs
H Su, L Han, X Huang - The journal of antibiotics, 2018 - nature.com
In recent years, incidences of invasive fungal infections have greatly increased, especially in
immunosuppressed patients, but most today's antifungal drugs are not completely effective …
immunosuppressed patients, but most today's antifungal drugs are not completely effective …
New facets of antifungal therapy
Invasive fungal infections remain a major cause of morbidity and mortality in
immunocompromised patients, and such infections are a substantial burden to healthcare …
immunocompromised patients, and such infections are a substantial burden to healthcare …
[HTML][HTML] New horizons in antifungal therapy
KM Pianalto, JA Alspaugh - Journal of Fungi, 2016 - mdpi.com
Recent investigations have yielded both profound insights into the mechanisms required by
pathogenic fungi for virulence within the human host, as well as novel potential targets for …
pathogenic fungi for virulence within the human host, as well as novel potential targets for …
[HTML][HTML] Current antimycotics, new prospects, and future approaches to antifungal therapy
G Wall, JL Lopez-Ribot - Antibiotics, 2020 - mdpi.com
Fungal infections represent an increasing threat to a growing number of immune-and
medically compromised patients. Fungi are eukaryotic organisms and, as such, there is a …
medically compromised patients. Fungi are eukaryotic organisms and, as such, there is a …